M1 Kliniken AG announced that the dividend of EUR 0.30 per share will be proposed at the Annual General Meeting.

The company reported preliminary consolidated earnings results for the year 2017. For the year, the group again significantly increased its sales and profits. Revenues increased by 31.3% from EUR 36.0 million in 2016 to EUR 47.2 million. The result from ordinary activities (EBT) rose by 34.2% from EUR 5.5 million in 2016 to EUR 7.4 million. Undiluted earnings per share were EUR 0.38 compared to EUR 0.30 a year ago.

The group benefits from the increasing demand for plastic and aesthetic beauty treatments in Germany. The profitable growth course is to be continued in 2018 and the international expansion is to begin.